Market Overview

Ebola Stocks Continue Higher

Related BCRX
Mid-Morning Market Update: Markets Edge Lower; Sotheby's Beats Q4 Views
22 Stocks Moving In Monday's Pre-Market Session
BioCryst Pharmaceuticals' (BCRX) CEO Jon Stonehouse on Q4 2016 Results - Earnings Call Transcript (Seeking Alpha)

With over 700 already dead, the worst Ebola outbreak in history is pressuring the demand for development of new drugs to fight the Ebola virus.

On Friday, The U.S. Food and Drug Administration said the agency stands ready to work with companies to develop drugs for patients "in dire need of treatment."

Some of the companies that are likely to benefit include Tekmira Pharmaceuticals (NASDAQ: TKMR), Nano Vircides (NASDAQ: NNVC) and BioCryst Pharamceuticals (NASDAQ: BCRX).

Shares of all three companies were trading higher on the open, with TKMR up nearly 15 percent at $16.50.

Posted-In: EbolaNews Global Movers


Related Articles (BCRX + NNVC)

View Comments and Join the Discussion!